Oblique is honored to introduce the progressive new identity for CTTI (Clinical Trials Transformation Initiative). The innovative logo is an exciting update from their old look. With a creative and engaging design, the new logo expresses collaboration, intelligence and quality.
CTTI is a public-private partnership founded by the U.S. Food and Drug Administration and Duke University to identify practices that will improve the quality and efficiency of clinical trials.